ITRM20040240A1 - Camptotecine coniugate in posizione 7 con antagonisti delle integrine. - Google Patents

Camptotecine coniugate in posizione 7 con antagonisti delle integrine.

Info

Publication number
ITRM20040240A1
ITRM20040240A1 IT000240A ITRM20040240A ITRM20040240A1 IT RM20040240 A1 ITRM20040240 A1 IT RM20040240A1 IT 000240 A IT000240 A IT 000240A IT RM20040240 A ITRM20040240 A IT RM20040240A IT RM20040240 A1 ITRM20040240 A1 IT RM20040240A1
Authority
IT
Italy
Prior art keywords
camptotecine
integrine
antagonists
conjugated
integrine antagonists
Prior art date
Application number
IT000240A
Other languages
English (en)
Inventor
Domenico Alloatti
Pozzo Alma Dal
Sabrina Dallavalle
Giuseppe Giannini
Lucio Merlini
Ming Hong Ni
Sergio Penco
Claudio Pisano
Maria Ornella Tinti
Loredana Vesci
Franco Zunino
Original Assignee
Ist Naz Stud Cura Dei Tumori
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori, Sigma Tau Ind Farmaceuti filed Critical Ist Naz Stud Cura Dei Tumori
Priority to IT000240A priority Critical patent/ITRM20040240A1/it
Publication of ITRM20040240A1 publication Critical patent/ITRM20040240A1/it
Priority to TW094113142A priority patent/TWI352703B/zh
Priority to BRPI0510983-3A priority patent/BRPI0510983A/pt
Priority to ES05742726T priority patent/ES2321114T3/es
Priority to PL05742726T priority patent/PL1753776T3/pl
Priority to US11/596,015 priority patent/US7705012B2/en
Priority to KR1020067025552A priority patent/KR101145815B1/ko
Priority to CN2005800152338A priority patent/CN1953989B/zh
Priority to PT05742726T priority patent/PT1753776E/pt
Priority to DE602005012390T priority patent/DE602005012390D1/de
Priority to CA002563708A priority patent/CA2563708A1/en
Priority to DK05742726T priority patent/DK1753776T3/da
Priority to AT05742726T priority patent/ATE420891T1/de
Priority to RSP-2009/0152A priority patent/RS51169B/sr
Priority to SI200530601T priority patent/SI1753776T1/sl
Priority to AU2005243417A priority patent/AU2005243417B2/en
Priority to JP2007512734A priority patent/JP4805917B2/ja
Priority to MXPA06012884A priority patent/MXPA06012884A/es
Priority to EP05742726A priority patent/EP1753776B1/en
Priority to PCT/IT2005/000260 priority patent/WO2005111063A1/en
Priority to ARP050101902A priority patent/AR048949A1/es
Priority to HR20090146T priority patent/HRP20090146T3/xx
Priority to CY20091100424T priority patent/CY1108985T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT000240A 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine. ITRM20040240A1 (it)

Priority Applications (23)

Application Number Priority Date Filing Date Title
IT000240A ITRM20040240A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
TW094113142A TWI352703B (en) 2004-05-13 2005-04-25 Camptothecins conjugated in position 7 with integr
PCT/IT2005/000260 WO2005111063A1 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
CA002563708A CA2563708A1 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
RSP-2009/0152A RS51169B (sr) 2004-05-13 2005-05-04 Kamptotecini konjugirani na položaju 7 sa cikličnim peptidima kao citostatička sredstva
PL05742726T PL1753776T3 (pl) 2004-05-13 2005-05-04 Kamptotecyny sprzężone w pozycji 7 z cyklicznymi peptydami jako czynniki cytostatyczne
US11/596,015 US7705012B2 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
KR1020067025552A KR101145815B1 (ko) 2004-05-13 2005-05-04 세포증식 억제제로서 7 번 위치에서 사이클릭 펩티드에공액된 캄토테신
CN2005800152338A CN1953989B (zh) 2004-05-13 2005-05-04 作为细胞抑制剂的在7位与环肽缀合的喜树碱
PT05742726T PT1753776E (pt) 2004-05-13 2005-05-04 Camptotecinas conjugadas na posição 7 com péptidos cíclicos como agentes citostáticos
DE602005012390T DE602005012390D1 (de) 2004-05-13 2005-05-04 In stellung 7 mit cyclischen peptiden konjugierte camptothecine als zytostatika
BRPI0510983-3A BRPI0510983A (pt) 2004-05-13 2005-05-04 camptotecinas conjugadas na posição 7 a peptìdeos cìclicos como agentes citoestáticos
DK05742726T DK1753776T3 (da) 2004-05-13 2005-05-04 Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler
AT05742726T ATE420891T1 (de) 2004-05-13 2005-05-04 In stellung 7 mit cyclischen peptiden konjugierte camptothecine als zytostatika
ES05742726T ES2321114T3 (es) 2004-05-13 2005-05-04 Camptotecinas conjugadas en posicion 7 con peptidos ciclicos como agentes citostacios.
SI200530601T SI1753776T1 (sl) 2004-05-13 2005-05-04 Kamptotecini, konjugirani v poloĺ˝aju 7 na cikliäśne peptide, kot citostatiäśna sredstva
AU2005243417A AU2005243417B2 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
JP2007512734A JP4805917B2 (ja) 2004-05-13 2005-05-04 細胞分裂阻害剤として７位にて環状ペプチドと接合したカンプトテシン
MXPA06012884A MXPA06012884A (es) 2004-05-13 2005-05-04 Camptotecinas conjugadas en posicion 7 a peptidos ciclicos como agentes citostaticos.
EP05742726A EP1753776B1 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
ARP050101902A AR048949A1 (es) 2004-05-13 2005-05-11 Camptotecina conjugada en posicion 7 con antagonistas de la integrina
HR20090146T HRP20090146T3 (en) 2004-05-13 2009-03-11 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
CY20091100424T CY1108985T1 (el) 2004-05-13 2009-04-10 Καμπτοθεκινες που ειναι συζευγμενες στη θεση 7 με κυκλικα πεπτιδια ως κυτταροστατικοι παραγοντες

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000240A ITRM20040240A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine.

Publications (1)

Publication Number Publication Date
ITRM20040240A1 true ITRM20040240A1 (it) 2004-08-13

Family

ID=34968014

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000240A ITRM20040240A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine.

Country Status (23)

Country Link
US (1) US7705012B2 (it)
EP (1) EP1753776B1 (it)
JP (1) JP4805917B2 (it)
KR (1) KR101145815B1 (it)
CN (1) CN1953989B (it)
AR (1) AR048949A1 (it)
AT (1) ATE420891T1 (it)
AU (1) AU2005243417B2 (it)
BR (1) BRPI0510983A (it)
CA (1) CA2563708A1 (it)
CY (1) CY1108985T1 (it)
DE (1) DE602005012390D1 (it)
DK (1) DK1753776T3 (it)
ES (1) ES2321114T3 (it)
HR (1) HRP20090146T3 (it)
IT (1) ITRM20040240A1 (it)
MX (1) MXPA06012884A (it)
PL (1) PL1753776T3 (it)
PT (1) PT1753776E (it)
RS (1) RS51169B (it)
SI (1) SI1753776T1 (it)
TW (1) TWI352703B (it)
WO (1) WO2005111063A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
EP2120948A1 (en) * 2007-02-13 2009-11-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
TW201004647A (en) * 2008-05-20 2010-02-01 Sigma Tau Ind Farmaceuti Novel dual targeting antitumoural conjugates
US8853151B2 (en) * 2009-06-30 2014-10-07 The Regents Of The University Of Michigan Pro-drug complexes and related methods of use
US9073974B2 (en) 2009-12-21 2015-07-07 The Regents Of The University Of California RGD-containing cyclic peptides
WO2011100688A1 (en) 2010-02-12 2011-08-18 Dana-Farber Cancer Institute, Inc. Improved antagonists of muc1
WO2013026015A1 (en) 2011-08-18 2013-02-21 Dana-Farber Cancer Institute, Inc. Muc1 ligand traps for use in treating cancers
CN102516258B (zh) * 2011-11-11 2014-06-25 正大天晴药业集团股份有限公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
US9044421B2 (en) 2012-03-28 2015-06-02 Genus Oncology, Llc Treating MUC1-expressing cancers with combination therapies
EP3310787B9 (en) * 2015-06-18 2020-07-01 Ramot at Tel-Aviv University Ltd. Taggable heteroaromatic drugs and conjugates thereof
US10494403B2 (en) * 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69209969T2 (de) * 1991-10-29 1996-09-12 Glaxo Wellcome Inc Wasserlösliche Camptothecinderivate
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
WO1998035940A1 (en) * 1997-02-14 1998-08-20 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
DE19815812A1 (de) 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
ATE216998T1 (de) 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
ATE438413T1 (de) * 1999-09-08 2009-08-15 Markus Albers Integrin-vermittelte arzneimittel-zielrichtung
EP1373501A2 (en) * 2000-10-06 2004-01-02 Novartis AG Targeting molecules for adenoviral vectors
WO2002096367A2 (en) * 2001-05-30 2002-12-05 Targesome, Inc. Targeted multivalent macromolecules

Also Published As

Publication number Publication date
AR048949A1 (es) 2006-06-14
AU2005243417A2 (en) 2005-11-24
KR101145815B1 (ko) 2012-05-16
DE602005012390D1 (de) 2009-03-05
CY1108985T1 (el) 2014-07-02
PL1753776T3 (pl) 2009-06-30
JP2008504235A (ja) 2008-02-14
HRP20090146T3 (en) 2009-05-31
BRPI0510983A (pt) 2007-12-04
AU2005243417B2 (en) 2011-07-07
ATE420891T1 (de) 2009-01-15
SI1753776T1 (sl) 2009-06-30
TW200606165A (en) 2006-02-16
US7705012B2 (en) 2010-04-27
CN1953989B (zh) 2012-10-10
CN1953989A (zh) 2007-04-25
EP1753776A1 (en) 2007-02-21
JP4805917B2 (ja) 2011-11-02
RS51169B (sr) 2010-10-31
MXPA06012884A (es) 2007-02-15
WO2005111063A1 (en) 2005-11-24
EP1753776B1 (en) 2009-01-14
AU2005243417A1 (en) 2005-11-24
ES2321114T3 (es) 2009-06-02
US20080033003A1 (en) 2008-02-07
CA2563708A1 (en) 2005-11-24
KR20070012530A (ko) 2007-01-25
TWI352703B (en) 2011-11-21
DK1753776T3 (da) 2009-05-11
PT1753776E (pt) 2009-03-05

Similar Documents

Publication Publication Date Title
DE602006011289D1 (de) Muster mit geringerem abstand im zusammenhang mit photolithographischen merkmalen
DE602005009657D1 (de) Übertragung in zwei Betriebsarten
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
DOP2006000278A (es) Glicosilación en la región variable
DE112006001565A5 (de) Nanopartikel-Wirkstoff-Konjugate
DE602005002401D1 (de) Selbsthemmender Leitungskontakt
DE112006003324T8 (de) Abtastvorrichtung mit modularen Teilen
FI20045026A (fi) Kytkinlaite
ITRM20040240A1 (it) Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
NO20054964L (no) Drivstoffdryppfanger
ITRM20040241A1 (it) Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ATE447977T1 (de) Biotin-diamino-derivate und ihre konjugate mit makrocyclischen chelationsmitteln
DE60329574D1 (de) Vorausladungsmechanismus mit Speicherabsicht
ITRM20040242A1 (it) "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
FI20040068A0 (fi) Kytkinlaite
ES2365717T5 (es) Vacunacion meningococica conjugada.
FR2881644B1 (fr) Composition cosmetique a texture fine.
FI20045499A0 (fi) Järjestely oskillointilaitteessa
NL1026779A1 (nl) Contactpen.
ITTS20040008U1 (it) La macchina delle coccole
FI20040423A0 (fi) Järjestely hississä
ITPG20050016A1 (it) Cosmeticus bibbia n.2
ITAN20050010A1 (it) Dispositivo per arrestare in apertura le imposte delle finestre
ES1057101Y (es) Dispositivo limitador de desplazamiento de cargas en estanterias.
ITPC20050014U1 (it) Porta con sopraluce avente il telaio in comune con quest'ultimo